Skip to main content
MESA LABORATORIES INC /CO/ logo

MESA LABORATORIES INC /CO/ — Investor Relations & Filings

Ticker · MLAB ISIN · US59064R1095 LEI · 549300ZCG738WLX8ZW79 US Manufacturing
Open in API
Filings indexed 1,017 across all filing types
Latest filing 2026-06-03 Share Issue/Capital Cha…
Country US United States of America
Listing US MLAB

About MESA LABORATORIES INC /CO/

https://mesalabs.com

Mesa Laboratories, Inc. designs, manufactures, and markets quality control products and services for regulated industries. The company specializes in life sciences tools and critical quality control solutions, including analytical instruments and related consumables. Its products are utilized primarily in the pharmaceutical, healthcare, and medical device sectors to ensure product safety, integrity, and performance. Mesa Laboratories focuses on applying technical expertise and technological innovation to help customers monitor and maintain high standards, supporting compliance with various regulatory requirements and international standards for quality management, testing, and calibration.

Recent filings

Filing Released Lang Actions
FORM S-8
Share Issue/Capital Change Classification · 87% confidence The document is a Securities and Exchange Commission Registration Statement on Form S-8, filed under the Securities Act of 1933 to register an additional 496,000 shares of common stock under the company’s Amended and Restated 2021 Equity Incentive Plan. This type of filing is used to authorize and register new share issuances in connection with equity compensation plans. Under the provided classification scheme, announcements or filings concerning new share issues or capital changes fall under Share Issue/Capital Change (SHA).
2026-06-03 English
FORM 10-K
Annual Report
2026-06-02 English
FORM 8-K
Report Publication Announcement Classification · 85% confidence The document is a Form 8-K current report announcing that the company has issued and furnished a press release containing its quarterly results (three and twelve months ended March 31, 2026) as Exhibit 99.1. It does not itself present the financial data, but simply announces and publishes a separate report (the press release). This fits the “Report Publication Announcement” category rather than an actual earnings release or other specific filing. Therefore, it should be classified as RPA.
2026-05-27 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-15 English
SCHEDULE 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)
Major Shareholding Notification
2026-03-27 English
FORM 8-K
Regulatory Filings
2026-03-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.